Researchers from Weill Cornell Medicine and the Burke Neurological Institute have developed a new drug that could make a big difference for people suffering from chronic nerve pain. This condition, ...
It could be, if it’s FDA-approved, the first of a new class of pain medications. And so what it’s doing is it’s targeting these sodium channels that are scattered along our nerve cells in ...
Earlier this year, the team published a review looking into existing treatments for chronic neuropathic pain and found that current medications and non-pharmacological treatments show little response.